Cargando…
Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice
BACKGROUND: Anti-Tumor Necrosis Factor-alpha therapy has become clinically important for treating inflammatory bowel disease. However, the use of conventional immunotherapy requires a systemic exposure of patients and collateral side effects. Lactic acid bacteria have been shown to be effective as m...
Autores principales: | Chiabai, Maria José, Almeida, Juliana Franco, de Azevedo, Mariana Gabriela Dantas, Fernandes, Suelen Soares, Pereira, Vanessa Bastos, de Castro, Raffael Júnio Araújo, Jerônimo, Márcio Sousa, Sousa, Isabel Garcia, de Souza Vianna, Leonora Maciel, Miyoshi, Anderson, Bocca, Anamelia Lorenzetti, Maranhão, Andrea Queiroz, Brigido, Marcelo Macedo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593574/ https://www.ncbi.nlm.nih.gov/pubmed/31238939 http://dx.doi.org/10.1186/s12896-019-0518-6 |
Ejemplares similares
-
Dendritic Cells Transfected with scFv from Mab 7.B12 Mimicking Original Antigen gp43 Induces Protection against Experimental Paracoccidioidomycosis
por: Ferreira, Karen S., et al.
Publicado: (2011) -
Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity
por: Siqueira, Isaque Medeiros, et al.
Publicado: (2017) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012) -
Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis
por: Siqueira, Isaque Medeiros, et al.
Publicado: (2020)